LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Computer-aided drug design for virtual-screening and active-predicting of main protease (M

    Dai, Renhui / Gao, Hongwei / Su, Ruiling

    Frontiers in pharmacology

    2023  Volume 14, Page(s) 1288363

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2023-11-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2023.1288363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Computer-aided drug design for the pain-like protease (PL

    Gao, Hongwei / Dai, Renhui / Su, Ruiling

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2023  Volume 159, Page(s) 114247

    Abstract: A new coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is a highly contagious virus and has caused a massive worldwide health crisis. While large-scale vaccination efforts are underway, the management of population ... ...

    Abstract A new coronavirus, known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is a highly contagious virus and has caused a massive worldwide health crisis. While large-scale vaccination efforts are underway, the management of population health, economic impact and asof-yet unknown long-term effects on physical and mental health will be a key challenge for the next decade. The papain-like protease (PL
    MeSH term(s) Humans ; SARS-CoV-2/metabolism ; COVID-19 ; Molecular Docking Simulation ; Peptide Hydrolases ; Protease Inhibitors/pharmacology ; Protease Inhibitors/therapeutic use ; Viral Nonstructural Proteins ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Drug Design ; Endopeptidases
    Chemical Substances Peptide Hydrolases (EC 3.4.-) ; Protease Inhibitors ; Viral Nonstructural Proteins ; Antiviral Agents ; Endopeptidases (EC 3.4.-)
    Language English
    Publishing date 2023-01-16
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2023.114247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes.

    Dai, Renhui / Sun, Yingni / Su, Ruiling / Gao, Hongwei

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2022  Volume 154, Page(s) 113576

    Abstract: Alzheimer's disease (AD) is a common neurodegenerative disease that often occurs in the elderly population. At present, most drugs for AD on the market are single-target drugs, which have achieved certain success in the treatment of AD. However, the ... ...

    Abstract Alzheimer's disease (AD) is a common neurodegenerative disease that often occurs in the elderly population. At present, most drugs for AD on the market are single-target drugs, which have achieved certain success in the treatment of AD. However, the efficacy and safety of single-target drugs have not achieved the expected results because AD is a multifactorial disease. Multi-targeted drugs act on multiple factors of the disease network to improve efficacy and reduce adverse reactions. Therefore, the search for effective dual-target or even multi-target drugs has become a new research trend. Many of results found that the dual-target inhibitors of the beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) and acetylcholinesterase (AChE) found from traditional Chinese medicine have a good inhibitory effect on AD with fewer side effects. This article reviews sixty-six compounds extracted from Chinese medicinal herbs, which have inhibitory activity on BACE1 and AChE. This provides a theoretical basis for the further development of these compounds as dual-target inhibitors for the treatment of AD.
    MeSH term(s) Acetylcholinesterase/metabolism ; Aged ; Alzheimer Disease/drug therapy ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Peptides/metabolism ; Aspartic Acid Endopeptidases/metabolism ; China ; Cholinesterase Inhibitors/metabolism ; Cholinesterase Inhibitors/pharmacology ; Cholinesterase Inhibitors/therapeutic use ; Humans ; Neurodegenerative Diseases/drug therapy ; Plants, Medicinal/metabolism
    Chemical Substances Amyloid beta-Peptides ; Cholinesterase Inhibitors ; Acetylcholinesterase (EC 3.1.1.7) ; Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; BACE1 protein, human (EC 3.4.23.46)
    Language English
    Publishing date 2022-08-22
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2022.113576
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top